# Dogwood Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/dogwood-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 17 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-16T13:53:20.439669+00:00 |
| Last reviewed | 2026-10-16T13:53:20.439669+00:00 |

## Identity

- Legal name: Dogwood Therapeutics, Inc.
- Display name: Dogwood Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-16T13:53:20.439669+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.817 |
| Directors | 9 |
| Committees | 0 |
| Governance events | 4 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Abel De La Rosa, Ph.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:5
- Alan Yu: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:6
- Angela Walsh: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:7
- David Keefer: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:8
- Greg Duncan: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:9
- John C. Thomas, Jr.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:10
- Melvin Toh, M.B.B.S.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:11
- R. Michael Gendreau, M.D., Ph.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:12
- Richard J. Whitley, M.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:13

## Executive leadership

- Angela Walsh: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:14
- Greg Duncan: Chairman and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:15
- R. Michael Gendreau, M.D., Ph.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:16
- Ralph Grosswald: Senior Vice President of Operations. Status: current. claim_id=alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:17

## Governance events

- CFO_CHANGED: Angela Walsh executive of Dogwood Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-16T13:53:20.439669+00:00. event_id=alpha:event:transition:furzg95gxchv
- CEO_CHANGED: Greg Duncan executive of Dogwood Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-16T13:53:20.439669+00:00. event_id=alpha:event:transition:94dgk71f86ptf
- EXECUTIVE_APPOINTED: R. Michael Gendreau, M.D., Ph.D. executive of Dogwood Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-16T13:53:20.439669+00:00. event_id=alpha:event:transition:19vhvpb1206sd5
- EXECUTIVE_APPOINTED: Ralph Grosswald executive of Dogwood Therapeutics, Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-16T13:53:20.439669+00:00. event_id=alpha:event:transition:n1rtw15kne34

## Scoped resources

- `alpha://company/dogwood-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record
- `alpha://company/dogwood-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=identity
- `alpha://company/dogwood-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/dogwood-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=board
- `alpha://company/dogwood-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=committees
- `alpha://company/dogwood-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=leadership
- `alpha://company/dogwood-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=ownership
- `alpha://company/dogwood-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=financials
- `alpha://company/dogwood-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/dogwood-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=compensation
- `alpha://company/dogwood-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=governance
- `alpha://company/dogwood-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/dogwood-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=audit
- `alpha://company/dogwood-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=legal
- `alpha://company/dogwood-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=risk
- `alpha://company/dogwood-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=cyber
- `alpha://company/dogwood-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/dogwood-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=agents
- `alpha://company/dogwood-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/dogwood-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=events
- `alpha://company/dogwood-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=relationships
- `alpha://company/dogwood-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=assessments
- `alpha://company/dogwood-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Abel De La Rosa, Ph.D.: Director. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb.
- Alan Yu: Director. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb.
- Angela Walsh: Director. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb.
- David Keefer: Director. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb.
- Greg Duncan: Director. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb.
- John C. Thomas, Jr.: Director. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb.
- Melvin Toh, M.B.B.S.: Director. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb.
- R. Michael Gendreau, M.D., Ph.D.: Director. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb.
- Richard J. Whitley, M.D.: Director. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb.
- Angela Walsh: Chief Financial Officer. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:14. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8bf65e37d51b0d1b07b1b2007b18b4d7ec4ad3540567c626a4b3aa522d7387fc.
- Greg Duncan: Chairman and Chief Executive Officer. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:15. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:027a3943ca43f47e7857a32c899828ce7eb9ee66af3bd313a1795f706b8ce10e.
- R. Michael Gendreau, M.D., Ph.D.: Chief Medical Officer. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:16. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:377adc06154cabb6ff4b20094e9108f0d15debe575ab3919f3ae89fd55f6b800.
- Ralph Grosswald: Senior Vice President of Operations. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:leadership_role:17. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:385b9de0bc4594a2f220bd1464b0ef9d3afd155065b8d67bb01bb58d3505a438.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Dogwood Therapeutics, Inc.. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b79ee49123ec45a66c63b84ba3b1c0ab3087fa4c38c0359adb920cd0f298a3a.

## Entity Status

- Public listing published. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b79ee49123ec45a66c63b84ba3b1c0ab3087fa4c38c0359adb920cd0f298a3a.

## Published Fact

- US. Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b79ee49123ec45a66c63b84ba3b1c0ab3087fa4c38c0359adb920cd0f298a3a.

## Security Listing

- DWTX (NASDAQ). Claim: alpha:claim:company:8a040bfe-26f9-4c83-9fb8-bd6e1af42ff9:security_listing:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8b79ee49123ec45a66c63b84ba3b1c0ab3087fa4c38c0359adb920cd0f298a3a.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:8b79ee49123ec45a66c63b84ba3b1c0ab3087fa4c38c0359adb920cd0f298a3a: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/dogwood-therapeutics-inc).
- alpha:projection-evidence:document:c6b6c8a98f2ff3de52141d157809b4e4a57a552bcae53dc0f2a1d8e71ce3acdb: [Dogwood Therapeutics, Inc. DEF 14A 2026-02-13](https://www.sec.gov/Archives/edgar/data/1818844/000110465926015180/dwtx-20260311xdef14a.htm).
- alpha:projection-evidence:document:8bf65e37d51b0d1b07b1b2007b18b4d7ec4ad3540567c626a4b3aa522d7387fc: [DWTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1818844/000110465926049277/dwtx-20260616xdef14a.htm).
- alpha:projection-evidence:document:027a3943ca43f47e7857a32c899828ce7eb9ee66af3bd313a1795f706b8ce10e: [DWTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1818844/000110465926049277/dwtx-20260616xdef14a.htm).
- alpha:projection-evidence:document:377adc06154cabb6ff4b20094e9108f0d15debe575ab3919f3ae89fd55f6b800: [DWTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1818844/000110465926049277/dwtx-20260616xdef14a.htm).
- alpha:projection-evidence:document:385b9de0bc4594a2f220bd1464b0ef9d3afd155065b8d67bb01bb58d3505a438: [DWTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1818844/000110465926049277/dwtx-20260616xdef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/dogwood-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/dogwood-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/dogwood-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/dogwood-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-10-16T22:30:07.041638+00:00; recorded 2026-10-16T22:30:07.041638+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.